Early, selective growth hormone administration may ameliorate left ventricular remodeling after myocardial infarction

Medical Hypotheses

Volumn 64, Issue 3, 2005, Pages 582-585

  Mitsi, A C ^a   Hatzistergos, K ^a   Baltogiannis, G G ^a   Kolettis, T M ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; GROWTH HORMONE; SOMATOMEDIN C;

ARTICLE; CARDIOMEGALY; CAUSE OF DEATH; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; DISABILITY; DRUG EFFICACY; DRUG MECHANISM; HEART INFARCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE; HEART PROTECTION; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; SCAR;

ANIMALS; DILATATION, PATHOLOGIC; GROWTH HORMONE; HEART FAILURE, CONGESTIVE; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MODELS, BIOLOGICAL; MYOCARDIAL INFARCTION; MYOCARDIUM; TIME FACTORS; VENTRICULAR FUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 11144334172     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2004.07.028     Document Type: Article

References (30)

1. J.L. Rouleau, M. Talajic, and B. Sussex Myocardial infarction patients in the 1990s - their risk factors, stratification and survival in Canada: the Canadian Assessment of Myocardial Infarction (CAMI) Study J Am Coll Cardiol 27 1996 1119 1127
2. H. Emanualson, B.W. Karlson, and J. Herlitz Characteristics and prognosis of patients with acute myocardial infarction in relation to occurence of congestive heart failure Eur Heart J 15 1994 761 768
3. M.A. Pfeffer, and E. Braunwald Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications Circulation 81 1990 1161 1172
4. Y. Fu, S. Goodman, W.C. Chang, F. van De Werf, C.B. Granger, and P.W. Armstrong Time to treatment influences the impact of ST-segment resolution on one-year prognosis: insights from the assessment of the safety and efficacy of a new thrombolytic (ASSENT-2) trial Circulation 104 2001 2653 2659
5. T.P. Wharton Jr., L.L. Grines, and M.A. Turco Primary angioplasty in acute myocardial infarction at hospitals with no surgery on-site versus transfer to surgical centers for primary angioplasty. The PAMI-No SOS study J Am Coll Cardiol 43 2004 1943 1950
6. S. Basu, R. Senior, U. Raval, R. van der Does, T. Bruckner, and A. Lahiri Beneficial effects of intravenous and oral carvedilol treatment in acute myocardial infarction: a placebo-controlled, randomized trial Circulation 96 1997 183 191
7. R.N. Doughty, G.A. Whalley, G. Gamble, S. MacMahon, and N. Sharpe Left ventricular remodeling with carvedilol in patients with congestive heart failure due to ischemic heart disease: Australia-New Zealand Heart Failure Research Collaborative Group J Am Coll Cardiol 29 1997 1060 1066
8. M.A. Pfeffer, G.A. Lamas, D.E. Vaughan, A.F. Parisi, and E. Brauwald Effect of captopril of progressive ventricular dilatation after anterior myocardial infarction N Engl J Med 319 1988 80 86
9. Pfeffer MA, Braunwald E, Moye LA, et al, for the SAVE Investigators. Effect of captopril on mortality and morbitity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. N Engl J Med 1992;327:669-77
10. J.S. Pirolo, G.M. Hutchins, and G.W. Moore Infarct expansion: pathologic analysis of 204 patients with a single myocardial infarct J Am Coll Cardiol 7 1986 349 354
11. R. Zak Development and proliferative capacity of cardiac muscle cells Circ Res 35 1974 17 26
12. M. Eghbali, O.O. Blumenfeld, and S. Seifter Localisation of types I, III and IV collagen mRNAs in rat heart cells by in situ hybridization J Mol Cell Cardiol 21 1989 103 113
13. V. de Gennaro Colonna, G. Rossoni, and D. Bonacci Worsening of ischemic damage in hearts from rats with selective growth hormone deficiency Eur J Pharmacol 314 1996 333 338
14. V. Locatelli, G. Rossoni, and F. Schweiger Growth-hormone independent cardioprotective effects of hexarelin in the rat Endocrinology 140 1999 4024 4031
15. M. Buerke, T. Murohara, C. Skurk, C. Nuss, K. Tomaselli, and A.M. Lefer Cardioprotective effect of insulin-like growth factor I in myocardial ischemia followed by reperfusion Proc Natl Acad Sci USA 92 1995 8031 8035
16. B. Li, M. Setoguchi, and X. Wang Insulin-like growth factor-1 attenuates the detrimental impact of nonocclusive coronary artery constriction on the heart Circ Res 84 1999 1007 1019
17. B.I. Jugdutt Prevention of ventricular remodeling post myocardial infarction: timing and duration of therapy Can J Cardiol 9 1993 103 114
18. B.I. Jugdutt Remodeling of the myocardium and potential targets in the collagen degradation and synthesis pathways Curr Drug Targets Cardiovasc Haematol Disord 3 2003 1 30
19. M.G. Sutton, and N. Sharpe Left ventricular remodeling after myocardial infarction: pathophysiology and therapy Circulation 101 2000 2981 2988
20. B.K. Podesser, D.A. Siwik, and F.R. Eberli ET (A)-receptor blockade prevents matrix metalloproteinase activation late postmyocardial infarction in the rat Am J Physiol Heart Circ Physiol 280 2001 H984 H991
21. Q.T. Nguyen, P. Cernacek, and A. Calderoni Endothelin A receptor blockade causes adverse left ventricular remodeling but improves pulmonary artery pressure after infarction in the rat Circulation 98 1998 2323 2330
22. S.T. Kelley, R. Malekan, and J.H. Gorman III Restraining infarct expansion preserves left ventricular geometry and function after acute anteroapical infarction Circulation 99 1999 135 142
23. D.L. Mann, and F.G. Spinale Activation of matrix metalloproteinases in the failing human heart: breaking the tie that binds Circulation 98 1998 1699 1702
24. B.I. Jugdutt, M.J. Joljart, and M.I. Khan Rate of collagen deposition during healing after myocardial infarction in the rat and dog models: mechanistic insights into ventricular remodeling Circulation 94 1996 94 101
25. L. Sacca, A. Cittadini, and S. Fazio Growth hormone and the heart Endocr Rev 15 1994 555 573
26. S. Fazio, D. Sabatini, and B. Capaldo A preliminary study of growth hormone in the treatment of dilated cardiomyopathy N Engl J Med 334 1996 809 814
27. J. Isgaard, C.H. Bergh, K. Caidahl, M. Lomsky, A. Hjalmarson, and B.A. Bengtsson A placebo-controlled study of growth hormone in patients with congestive heart failure Eur Heart J 19 1998 1704 1711
28. A. Cittadini, J.D. Grossman, and R. Napoli Growth hormone attenuates early left ventricular remodeling and improves cardiac function in rats with large myocardial infarction J Am Coll Cardiol 29 1997 1109 1116
29. H. Jin, R. Yang, and H. Lu Effects of early treatment with growth hormone on infarct size, survival, and cardiac gene expression after acute myocardial infarction Growth Horm IGF Res 12 2002 208 215
30. V. Jayasankar, L.T. Bish, T.J. Pirolli, M.F. Berry, J. Burdick, and Y.J. Woo Local myocardial overexpression of growth hormone attenuates postinfarction remodeling and preserves cardiac function Ann Thorac Surg 77 2004 2122 2129